Q1 2017 Holdings
Filed 2017-05-15 | 65 holdings | $115.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Healthcare(ACHC) | COMMON | 00404A109 | $30.1M | 691,010 | 26.2% |
| Biomarin Pharmac Inc(BMRN) | COMMON | 09061G101 | $27.7M | 315,233 | 24.0% |
| Acadia Pharmaceuticals(ACAD) | COMMON | 004225108 | $23.1M | 671,113 | 20.0% |
| Collegium Pharmaceutical(COLL) | COMMON | 19459J104 | $12.9M | 1,279,247 | 11.2% |
| Accuray Inc(ARAY) | COMMON | 004397105 | $11.8M | 2,482,621 | 10.2% |
| Biogen Inc(BIIB) | COMMON | 09062X103 | $3.2M | 11,711 | 2.8% |
| Agios Pharmaceuticals(AGIO) | COMMON | 00847X104 | $3.0M | 51,200 | 2.6% |
| Corvus Pharmaceuticals(CRVS) | COMMON | 221015100 | $1.4M | 67,200 | 1.2% |
| Alnylam Pharmaceuticals(ALNY) | COMMON | 02043Q107 | $1.3M | 24,899 | 1.1% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $45.8K | 720,982 | 0.0% |
| Johnson & Johnson(JNJ) | COMMON | 478160104 | $42.6K | 342,350 | 0.0% |
| Pfizer Inc(PFE) | COMMON | 717081103 | $39.3K | 1,149,372 | 0.0% |
| Neurocrine Biosciences(NBIX) | COMMON | 64125C109 | $36.8K | 851,019 | 0.0% |
| Novartis AG(NVSN) | SP ADR | 66987V109 | $35.1K | 472,296 | 0.0% |
| Celgene Corp(CELG) | COMMON | 151020104 | $33.9K | 272,066 | 0.0% |
| Abiomed Inc(ABMDEUR) | COMMON | 003654100 | $32.8K | 261,691 | 0.0% |
| Amicus Therapeutics(FOLD) | COMMON | 03152W109 | $30.7K | 4,311,696 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $30.3K | 357,341 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $30.3K | 173,679 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COMMON | 670704105 | $29.3K | 391,989 | 0.0% |
| Teladoc Inc(TDOC) | COMMON | 87918A105 | $26.5K | 1,058,553 | 0.0% |
| Teva Pharmaceutical(TEVA) | SP ADR | 881624209 | $24.2K | 753,821 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $23.8K | 610,743 | 0.0% |
| Portola Pharmaceuticals | COMMON | 737010108 | $23.7K | 604,041 | 0.0% |
| Intuitive Surgic Inc(ISRG) | COMMON | 46120E602 | $22.0K | 28,672 | 0.0% |
| Edwards Lifescience(EW) | COMMON | 28176E108 | $18.9K | 200,479 | 0.0% |
| Wright MED Group N V | ORD SHS 0.03 PAR | N96617118 | $18.1K | 581,222 | 0.0% |
| Aerie Pharmaceuticals(AERIEUR) | COMMON | 00771V108 | $17.7K | 389,423 | 0.0% |
| K2m Group Holdings | COMMON | 48273J107 | $17.2K | 836,520 | 0.0% |
| Alder Biopharmaceuticals(ALDR1EUR) | COMMON | 014339105 | $14.8K | 713,119 | 0.0% |
| Nxstage Medical | COMMON | 67072V103 | $13.5K | 504,568 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $13.0K | 489,267 | 0.0% |
| Global Blood Therapeutics | COMMON | 37890U108 | $12.7K | 345,582 | 0.0% |
| Integra Lifescience(IART) | COMMON | 457985208 | $8.5K | 202,499 | 0.0% |
| Endo Intl PLC | SHS | G30401106 | $8.1K | 730,150 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $7.9K | 141,046 | 0.0% |
| Envision Healthcare | COMMON | 29414D100 | $7.7K | 125,050 | 0.0% |
| Novo-Nordisk AS(NVO) | ADR | 670100205 | $7.5K | 217,480 | 0.0% |
| Advaxis Inc | COMMON | 007624208 | $6.9K | 839,774 | 0.0% |
| Momenta Pharmaceuticals(MNTA) | COMMON | 60877T100 | $6.1K | 460,300 | 0.0% |
| Kite Pharma Inc | COMMON | 49803L109 | $5.0K | 63,520 | 0.0% |
| Masimo Corp(MASI) | COMMON | 574795100 | $5.0K | 53,300 | 0.0% |
| RA Pharmaceuticals | COMMON | 74933V108 | $4.8K | 225,340 | 0.0% |
| DBV Technologies | SP ADR | 23306J101 | $4.7K | 133,499 | 0.0% |
| Loxo Oncology Inc | COMMON | 548862101 | $3.8K | 90,390 | 0.0% |
| Molina Healthcare(MOH) | COMMON | 60855R100 | $3.7K | 81,575 | 0.0% |
| PTC Therapeutics I(PTCT) | COMMON | 69366J200 | $3.5K | 351,135 | 0.0% |
| Acceleron Pharma(XLRN) | COMMON | 00434H108 | $3.3K | 126,400 | 0.0% |
| Intersect ENT Inc | COMMON | 46071F103 | $2.5K | 143,240 | 0.0% |
| LA Jolla Pharmaceutical(LJPC) | COMMON | 503459604 | $2.3K | 78,700 | 0.0% |